Legislation Clarifying Opioid Reporting Requirements Passes Committee > Hospital Association of Pennsylvania


Login to view your account.

Don't have an account? Click here.


Legislation Clarifying Opioid Reporting Requirements Passes Committee

December 06, 2017

The House Human Services Committee passed legislation, Senate Bill 728, to exempt epilepsy drugs from the Prescription Drug Monitoring Program (PDMP) requirements. The prime sponsor, Senator Gene Yaw (R-Lycoming), indicated that policymakers have been made aware of the non-narcotic/non-opioid and non-addictive nature of these drugs.

Requiring the query of the PDMP prior to prescribing schedule V epilepsy drugs caused concern around timely access and necessary care for those suffering from epilepsy and seizure disorders.

The PDMP is a program to track opioid prescribing and patient usage in an effort to curb opioid abuse and came online during the fall of 2016. At the time of passage of legislation creating the PDMP, schedule V epilepsy drugs were included in the medications requiring the query of the PDMP by prescribers when the medication is prescribed.

The legislation now heads for consideration of the full house before heading to the Governor for his signature.

HAP supports this effort to address unintended consequences of the initial PDMP legislation and will continue to track this and other opioid-related issues.

For more information or if you have questions, please contact Stephanie Watkins, HAP’s vice president, state legislative advocacy.

« Close